Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

New PPAR agonists emerge from Shionogi R&D

Jan. 11, 2007

Anthera cleared to study A-001 in hospitalized patients with sickle cell disease

Jan. 11, 2007

NBI-56418 reduces endometriosis symptoms in phase II trial

Jan. 11, 2007

European approval for once-weekly NeoRecormon

Jan. 10, 2007

Alkermes and Lilly sign manufacturing agreement for AIR Inhaled Insulin

Jan. 10, 2007

New phase II study evaluates R-788 in ITP

Jan. 10, 2007

Targeting TRPV1 for the treatment of type 1 diabetes

Jan. 10, 2007

OSI licenses GKA program for type 2 diabetes to Lilly

Jan. 9, 2007

Merck & Co. reports preliminary in vivo results of novel DPP-IV inhibitor

Jan. 9, 2007

Recent patents reveal discovery of novel antidiabetic agents

Jan. 8, 2007

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 15, 2026.
ASGCT 2026: Circular RNA, the new beast in gene and cell therapy
BioWorld
Circular RNA (circRNA) is not a new concept, but it is a novel strategy in the field of gene and cell therapy. While mRNA vaccines have revolutionized medicine,...
ASGCT 2026: Directed evolution in gene therapy
BioWorld
Directed evolution has become a central pillar in gene therapy. This engineering strategy enables the generation of more efficient variants of genetic editors and...
ASGCT 2026: Uncovering the mechanisms of AAV toxicity
BioWorld
Gene therapies rely on vectors to reach the target tissue where they act, such as adeno-associated viruses (AAVs) or lipid nanoparticles (LNPs), among other...
Biogen AD drug shows tau, cognition benefit, despite trial miss
BioWorld
Biogen Inc. has decided to advance diranersen (BIIB-080) into registrational trials for early Alzheimer’s disease, even though the antisense oligonucleotide...